InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Burrell Terry-Ann, Chief Financial Officer. Director active across 2 companies, notably Beam Therapeutics Inc.. Cumulatively, 24 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €476k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Burrell Terry-Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
1,843 shares0Class A Common StockSEC:0001601830-24-000097:0
13,097 shares0Class A Common StockSEC:0001601830-24-000073:0
12,500 shares0Common StockSEC:0000950170-24-049854:0
5,446 shares@ US$32.126.4% of flowCommon StockSEC:0000950170-24-041437:0
1,467 shares0Class A Common StockSEC:0001601830-24-000028:0
27,500 shares0Common StockSEC:0000950170-24-040154:0
24,302 shares@ US$11.2501100.0% of flowClass A Common StockSEC:0001209191-23-042305:0
12,612 shares0Class A Common StockSEC:0001209191-23-038838:0
2,454 shares@ US$30.312.7% of flowCommon StockSEC:0000899243-23-010815:0
20,000 shares0Common StockSEC:0000899243-23-010132:0
1,102 shares@ US$13.680.5% of flowCommon StockSEC:0000899243-23-002957:0
5,426 shares@ US$13.682.7% of flowCommon StockSEC:0000899243-23-002666:0
39,886 shares@ US$13.6819.9% of flowCommon StockSEC:0000899243-23-002260:0
1,821 shares0Class A Common StockSEC:0001209191-23-002059:0
1,265 shares0Class A Common StockSEC:0001209191-22-052911:0
1,631 shares0Class A Common StockSEC:0001209191-22-041276:0
18,145 shares0Class A Common StockSEC:0001209191-22-037631:0
1,788 shares0Class A Common StockSEC:0001209191-22-023316:0
15,000 shares0Common StockSEC:0000899243-22-013485:0
763 shares0Class A Common StockSEC:0001209191-22-002050:0
629 shares0Class A Common StockSEC:0001209191-21-059745:0
382 shares0Class A Common StockSEC:0001209191-21-045551:0
30,000 shares@ US$13.6820.6% of flowCommon StockSEC:0000899243-21-027313:0
45,000 shares@ US$13.6830.7% of flowCommon StockSEC:0000899243-21-026779:0
24 of 24 declarations
About Burrell Terry-Ann
Burrell Terry-Ann is Chief Financial Officer at Beam Therapeutics Inc. and a director at Recursion Pharmaceuticals, INC. She has 24 filings in total. Across the 24 most recent sampled filings, sales total 476399 EUR, the period runs from 2021-06-30 to 2024-07-03, and the modal transaction nature is Attribution.
